We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NASTECH PHARMA ENTERS DEVELOPMENT DEAL WITH AMYLIN PHARMA
NASTECH PHARMA ENTERS DEVELOPMENT DEAL WITH AMYLIN PHARMA
June 26, 2006
Nastech Pharmaceutical
Company Inc. entered a agreement with Amylin Pharmaceuticals, Inc. to develop
a nasal spray formulation of exenatide.
StreetInsider.com (http://www.streetinsider.com/news.php?id=988986&st=p)
